Antitrust and Private Equity – Parental Liability Rules Can Allow Authorities to Claw Back Profits In UK and Europe
By: David Gallagher (The Thicket)
Private equity (PE) is in focus for antitrust authorities. In a merger control context, concerns around roll-up and keeping the bigger picture in mind occupy both Jonathan Kanter at the DOJ and Lina Khan at the FTC. My colleague Stijn Huijts covered this in his 13 June 2022 blog.
Consideration of the PE angle is not limited to the US. Nor is it limited to mergers. It is also something that the UK Competition and Markets Authority (CMA) has been grappling with in its recent Liothyronine and Hydrocortisone abuse of dominance decisions.
CMA Liothyronine and Hydrocortisone decisions include hefty fines for former PE owners
The CMA’s Liothyronine excessive pricing decision sets out how HgCapital and Cinven were party to the underlying antitrust breach under the laws on parental liability. HgCapital was fined £8.6m and Cinven was fined £51.9m. This is despite their involvement with the pharma company selling Liothyronine having ended in 2015 and 2018 respectively. The PE firms’ appeals to the Competition Appeal Tribunal (CAT) will be heard in September 2022.
In the CMA’s Hydrocortisone decision, the CMA fined Cinven £35.1m in total. Again, Cinven’s relationship with the underlying pharma business ended in 2018. Cinven will be at the CAT appealing this decision in November 2022…
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI